Evidence map›Paper›PMID 30610466›Full record

ReviewPathology oncology research : POR2019

Slit/Robo Signaling Pathway in Cancer; a New Stand Point for Cancer Treatment.

Zahra Koohini, Zohreh Koohini, Shahram Teimourian

Abstract readReview
PubMed Publisher
In one paragraph

Review in Pathology oncology research : POR, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.2field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 28 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Genes in Axonal Regeneration.Molecular neurobiology · 2024
    Review
  11. Review
  12. Article
  13. Article
  14. Science advances · 2023
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Role of Slit/Robo Signaling pathway in Bone Metabolism.International journal of biological sciences · 2022
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Zahra KoohiniDepartment of Medical Genetics, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Zohreh KoohiniDepartment of Immunology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
Shahram TeimourianDepartment of Medical Genetics, School of Medicine, Iran University of Medical Sciences, Tehran, Iran. teimourian.sh@iums.ac.ir.
Iran University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Angiogenesis and metastasis are two critical steps for cancer cells survival and migration. The microenvironment of tumor sphere induces new blood vessels formation for enhancing tumor mass. Preexisting capillaries and postcapillary venules in tumors bring about new blood vessels. ROBO1-ROBO4 are transmembrane receptors family which act as guidance molecules of the nervous system. The SLITs family is secreted glycoproteins that bind to these receptors. SLIT-ROBO signaling pathway plays an important role in neurogenesis and immune response. Linkage between ROBOs and their ligands (SLITs) induce chemorepllent signal for regulation of axon guidance and leukocyte cell migration, recent finding shows that it is also involved in endothelial cell migration and angiogenesis in various type of cancers. In this article we review recent finding of SLIT-ROBO pathway in angiogenesis and metastasis.

Indexed as

Antineoplastic AgentsHumansNeoplasmsNeovascularization, PathologicNerve Tissue ProteinsReceptors, ImmunologicRoundabout ProteinsSignal TransductionAntineoplastic AgentsNerve Tissue ProteinsReceptors, ImmunologicRoundabout ProteinsSLIT1 protein, humanRoboSliteTumor angiogenesisTumor markers

Identifiers

PMID30610466
OpenAlexW2906807606

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.